Acceptability of HIV self-testing in sub-Saharan Africa: scoping study. by Harichund, Charlene. & Moshabela, Mosa.
Acceptability of HIV Self-testing in sub-Saharan Africa: Scoping 
study
C Harichund1 and M Moshabela2,3
1Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
2Department of Rural Health, School of Nursing and Public Health, University of KwaZulu-Natal, 
Durban, South Africa
3Africa centre for Population Health, Mtubatuba, South Africa
Abstract
Several HIV testing models have been implemented in sub-Saharan Africa (SSA) to improve 
access to HIV testing, but uptake remains poor. HIV Self-Testing (HIVST) is now available, and 
may serve to overcome barriers of current testing models which include stigma, discrimination and 
non-confidential testing environments. A scoping study was conducted to provide an overview of 
the current literature in SSA, as well as identify future research needs to scale-up HIVST and 
increase HIV testing uptake. The outcome of the review indicated only 11 reported studies to date, 
showing variable acceptability (22.3% – 94%) of HIVST, with acceptability of HIVST higher 
among men than women in SSA. We conclude that research around HIVST in SSA is still in its 
infancy, and further implementation research and interventions are required to improve 
acceptability of HIVST among diverse study populations, failing which policy adoption and scale-
up may be hindered.
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INTRODUCTION
Despite concerted efforts in engaging community members to get tested and know their HIV 
status, uptake of HIV testing has not been optimal globally (1). Lack of HIV awareness is a 
rate limiting step for anti-retroviral therapy (ART) initiation, and will naturally hinder 
success of global initiatives intended to eliminate HIV by 2030 (1, 2). The United Nations 
Programme on HIV/AIDS (UNAIDS) has set an ambitious 90-90-90 goal to help end the 
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AIDS epidemic, through which 90% of people living with HIV should know their HIV 
status in order to allow for successful subsequent treatment initiation and viral suppression 
(2). As a result, researchers are investigating new approaches to HIV testing that would 
increase the uptake, and in return, lead to early HIV diagnosis and treatment initiation, as 
well as prevention options for people who test HIV negative (3–5). A newer approach to 
HIV testing, HIV Self-Testing (HIVST), has received global recognition as an alternate 
method to HIV testing. Growing evidence suggests that HIVST will likely serve to 
overcome several persisting barriers associated with current HIV testing models (3, 6). 
Barriers such as HIV-related stigma and discrimination, poor HIV testing facilities, 
excessive travel costs, inaccessible testing for hard-to-reach populations and lack of privacy 
and confidentiality seem to explain poor uptake of HIV testing associated with current HIV 
testing models, and have therefore created a niche for the adoption of HIVST. (3, 6–8).
Globally, there is strong evidence to support the potential of HIVST to access hard-to-reach 
study populations, but the acceptability levels of HIVST among these key populations has 
been found to vary widely in both developed and developing countries (6, 9–12). Studies 
have reported acceptability of HIVST ranging between 20.3% and 95% collectively among 
men-who-have-sex-with-men (MSM) (10, 13–19), female sex workers (16), and transgender 
women (19), but also among men and women targeted by gender (11, 20, 21). Globally, 
research evidence around differences in acceptability of HIVST between men and women is 
limited. Much of the HIVST research foci among these target groups have been directed 
toward issues inclusive of regulatory, policy and ethics, (9, 10, 22, 23), cost and distribution 
of HIVST kits (9), linkage to care (24, 25), and feasibility of implementation (18, 26). 
Whilst global HIVST research efforts are directing innovative research towards key 
populations that are hard-to-reach, such breakthroughs are also much needed in sub-Saharan 
Africa (SSA), where targeted populations should include the general population in addition 
to key populations. However, very little evidence for the use of HIVST exists in SSA, and 
adoption of this innovation is lagging behind many developed and developing countries. 
According to the UNAIDS technical report, evidence around acceptability and factors 
affecting policy development is limited in SSA, thus preventing scale-up of HIVST (27).
In SSA, voluntary counselling and testing (VCT), and its variations in design, is the most 
widely recommended model of HIV testing, where testing may be initiated by the patient or 
health worker. However, reported disadvantages of the VCT model include stigma and 
discrimination when presenting at HIV testing facilities to test (28), staff burnout at 
healthcare centres (28), inability to reach target populations for HIV testing (29, 30), high 
costs associated with implementing testing method (30), involuntary HIV status disclosure 
and possible adverse social impacts (28, 31). In light of the imperative to expand HIV testing 
uptake, frequency and awareness, new testing strategies such as HIVST will become 
important to consider for the general and key populations in SSA, where the burden of HIV 
remains the highest in the world (4). However, the current body of evidence on HIVST 
appear to be disproportionately lower in SSA given the burden, and the adoption of HIVST 
is only a recent development. We therefore sought to synthesize the evidence base on the 
growing adoption of HIVST in SSA using a scoping study methodology, so as to profile the 
target populations and their acceptability rates of HIVST. We further aimed to map and 
locate the current literature on HIVST within SSA in the broader context of the global 
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evidence base, so as to identify gaps to be potentially addressed in future research, as well as 
related policy implications.
METHODS
The Arksey and O’Malley scoping study methodology (32) was used for this review. Due to 
the exploratory nature of our review, and the intent to “map” the existing research and look 
for recurring themes within the literature, a scoping review methodology was the most 
appropriate methodological approach (33–35). Five main phases are followed in scoping 
reviews: 1) identifying the research question, 2) identifying relevant studies, 3) study 
selection, 4) charting the data, and 5) collating, summarizing and reporting the results. 
Scoping review methodology is similar to systematic reviews on the basis of rigorous 
literature techniques, but differ in that the criteria for inclusion are not based on quality of 
the study designs, but on relevance of the study to the question. As a result, studies with 
mixed designs can be reviewed, including both qualitative and quantitative studies. All data 
from the included studies are charted, emerging themes are identified and gaps are 
highlighted. Due to the broad inclusion criteria in scoping reviews when compared to 
systematic reviews, scoping studies tend to include a large body of published research, and 
identified gaps can help researchers guide future research.
Identifying the research question
Arksey and O’Malley (32) recommended a wide and inclusive approach to setting research 
questions in order to generate breath of coverage in the literature search process. Therefore, 
the research question for this scoping study was: what is known from existing literature 
about acceptability of HIV self-testing in SSA? The following questions were included to 
guide the main research question: 1) what is known in the literature? 2) what are the research 
gaps? and 3) what are the future needs?
Identifying relevant studies
According to Arksey and O’Malley, several literature sources should be reviewed to provide 
a wide breadth of coverage of the available literature (32). For this scoping review, English 
electronic academic databases were reviewed, which included: PubMed, Science Direct, 
Web of Science, African Journals Online and African Medicus Index. In addition, local and 
international policies on HIV self-testing were reviewed. Key words used in the search were 
“HIV”; “Self-testing”; “Testing methods” and “Acceptability”. Two full searches were 
conducted in all electronic academic databases from August 2015 to January 2017. Four 
stages of exclusion or inclusion were applied following outcome of search results: 1) Year 
(articles were excluded if pre year 1990), 2) Title (if title was irrelevant then article was 
excluded), 3) Abstract (if abstract was irrelevant, article was excluded), and 4) Article (if 
irrelevant, article was excluded).
Study selection
To ensure standardized study selection that was relevant to the research question, the process 
was guided by the following inclusion criteria: 1) Articles published from the year 1990 
onwards, 2) Only articles published in English language, 3) Qualitative and Quantitative 
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research methods and 4) Studies from SSA. Qualitative and quantitative research methods 
were included to allow for a broader range of studies on the basis of their relevance, and in 
keeping with scoping review methodology. Since scoping reviews are exploratory by design, 
results from all studies in SSA on the topic were included. Articles related to home-based 
self-testing were included, but other home-based testing were excluded from study selection 
process when implemented by a healthcare worker or lay counsellor. HIVST was 
specifically defined, “as a process by which an individual performs a rapid diagnostic HIV 
test and interprets the results themselves”.
Charting the data
Data extraction from articles that met the inclusion criteria was conducted in accordance 
with recommendations by Arksey and O’Malley (32). Charting involved synthesising and 
interpreting data according to key issues and themes. A data extraction tool was developed, 
using the program Excel, to ensure relevant and efficient data extraction of information 
related to HIVST in SSA. Charting of data involved having to enter data into the Excel 
spreadsheets for each selected article, and ensuring data captured is comparable between 
included articles.
Collating, summarizing and reporting the results
Levac et al., (2010) (36) recommended an approach to stage five of the scoping review that 
includes three steps (analysing the data, reporting results and applying meaning to the 
results) to increase consistency in reporting of results. After collation of data, summaries 
were generated and combined for reporting purposes. Research gaps were identified based 
on recommendations from authors, key findings, gaps in charts and lack of evident research 
from the chart.
RESULTS
A total of 551 relevant study titles, as shown in Figure 1, met the eligibility criteria for the 
scoping review. Further screening of the titles, resulted in exclusion of 350 studies which 
were duplicates retrieved between databases. A further 121 studies were excluded after 
abstract review found content to be irrelevant to this scoping review. Review of full articles 
resulted in exclusion of 69 studies conducted outside of SSA. Ultimately, a total of 11 
articles on HIVST in SSA were included for analysis in this review, presented in Table I. 
However, only 9 of 11 studies reported specifically on acceptability in general of HIVST. 
Quantitative assessment was method of choice for most studies, used in eight of the studies. 
However, as HIVST is a relatively novel area of research, the three qualitative studies 
included in this review were also found to be useful in understanding perceived concerns 
around adoption and scale-up of HIVST. Nine of eleven studies reported on acceptability of 
HIVST (Table I), with acceptability rates ranging from 22.3% (37) to 94% (12) across 
studies conducted in SSA. The majority of studies around HIVST within SSA were 
conducted in South Africa (45%), Kenya (36%) and Malawi (36%). Further emerging 
themes from the current scoping review included target populations, benefits of HIVST, 
need for counselling, linkage to care, usability of HIVST kits, costs of test kits for HIVST, in 
terms of affordability and informing the scale-up of HIVST.
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Acceptability across different target populations
The majority of studies conducted in SSA included study populations of healthcare workers, 
policy makers, men only and general population. HIVST acceptability was higher among 
health professionals than community health workers, the latter having levels similar to the 
one study on policy makers and members of the civil society. Reviewed literature also 
highlighted the use of HIVST to access hard-to-reach populations to test for HIV, but men 
were the only sub-population identified in two studies (6, 38–41). Four studies evaluated 
acceptability of HIVST on target populations inclusive of both men and women in SSA, 
with acceptability ranging from 22.3% to 94% (Table I). In each of the four studies, men 
indicated higher acceptability for HIVST due to lower direct non-medical costs and not 
being absent from work (12, 37, 42, 43). Also, acceptability rates in studies with men only 
(12, 39) were higher (70% – 94%) when compared to studies combining both men and 
women (22.3% – 64%) (12, 37, 39, 43). Uptake of HIV testing is lower among men using 
current HIV testing models, although there were no studies targeting women only (44). 
Therefore, higher acceptability rates among men suggests HIVST may be best suited to 
increase their uptake of HIV testing. However, further research is required to understand 
reasons for these gender-disparate lower acceptability rates of HIVST among women. 
Furthermore, future research should include explicit descriptions of targeted general 
populations, as well as sub-groups of key populations, and assess consistency of 
acceptability levels.
Benefits of HIVST
Evidence related to advantages and benefits of HIVST in SSA were reported in five studies 
(37, 38, 40, 41, 45). Several authors reported increased confidentiality and privacy, 
decreased burden on healthcare system, decreased coercive testing by healthcare workers, 
and decreased stigma and discrimination associated with HIV testing as advantages of 
HIVST (37, 40, 41, 45). Autonomy to make one’s own choice of HIV testing method was 
also cited as advantageous by van Dyk et al. (41). Makusha et al. (38) reported that HIVST 
has the potential to address gender disparate barriers to testing, often encountered by males 
at HIV testing centres, such as non-male friendly testing spaces, inconvenient operating 
hours and healthcare provider attitudes that may not be sensitive to men’s needs. Also, study 
outcomes from current literature on the advantages of HIVST reiterate the argument that 
HIVST should be offered as a complementary HIV testing method to overcome current 
barriers associated with conventional HIV testing approaches (voluntary counselling and 
testing, provider-initiated counselling and testing, etc).
Drawbacks of HIVST
Despite compelling evidence around advantages of HIVST, policy makers, key stakeholders 
and community members have reported several concerns associated with HIVST, which 
warrant further research to ensure that HIVST scale-up is not compromised (6, 38, 40, 46–
48). Formative research is required to address concerns identified during the scoping review, 
including lack of face-to-face counselling, poor linkage to care and potential for social harm.
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Face-to-face counselling—Mixed reactions toward the need for face-to-face HIV 
counselling during HIVST were noted (37, 38, 40, 41, 45). Counselling is considered an 
essential component of all current testing models (38). In keeping with this perspective, 
studies conducted with academics, key stakeholders and community leaders perceived 
absence of face-to-face HIV counselling as a disadvantage in two studies (38, 40). Key 
stakeholders believed that complete lack of face-to-face HIV counselling could lead to 
increased risk of distress and suicide (38). However, outcomes from the remaining two 
studies, involving both men and women from community, indicated the need to consider 
face-to-face HIV counselling on the basis of user preference (41). Van Dyk et al. (41) 
reported 22.2% of participants who felt that face-to-face HIV counselling was not necessary. 
Participants from another paper published by van Dyk et al. (37) indicated that they were 
comfortable to test for HIV, but did not want to be counselled by someone they did not know 
as they would likely be negatively judged. Participants who were willing to test for HIV 
through HIVST suggested telephone counselling as a more suitable counselling method 
when compared to face-to-face HIV counselling (37). Given varied preference to counselling 
in current studies in SSA, alternate methods to face-to-face counselling should be 
investigated.
Linkage to care—Linkage to care following a positive HIV result was highlighted as a 
major concern throughout literature from SSA which was identified during the scoping 
review (6, 38, 40, 41, 45, 48, 49). Researchers have found that adequate linkage to care, 
whereby participants access treatment or care facilities after testing for HIV, is an important 
component of the HIVST model and requires more formative research (6, 38, 39, 47–49). 
Choko et al. (49) reported 41.7% of participants linked to care following a positive HIV 
result in a study population of men and women. Lack of counselling may be linked to 
inadequate linkage to care as patients who test positive for HIV would not have adequate 
information to access care and treatment (38). Limited research has been conducted on 
linkage to care following HIVST. Algorithms and methods that ensure adequate linkage to 
care need to be evaluated through future research.
Social Harm—Incidents of harm such as suicide was not reported in the literature. 
However, Makusha et al. (38) reported that several stakeholders feared that people who test 
through HIVST may not be able to handle their results and actions taken by such people 
could be harmful to them. Choko et al. (49) reported 3% of coercive testing by partners in 
their study (38). Coercive testing may lead to gender-based violence between partners, but 
may also be experienced between family members. Potential for social harm through HIVST 
in SSA has mainly been reported through perceptions of community health care workers and 
key stakeholders (38, 49). Therefore, research gaps exist for evidence of social harm from 
general community members and key populations using HIVST, and methods to prevent 
occurrence of social harm should be designed and evaluated.
Usability of Test Kits for HIVST
Rapid oral fluid HIV tests and rapid finger prick test kits were used in studies reviewed as 
part of scoping review (12, 47, 49). The overall concern raised across studies reporting on 
usability of HIVST kits was suitability of instructions for diverse target populations (6, 12, 
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50). Researchers reported that the language of instructions, and the information relevant to 
linkage to care should be adequately recorded in user instructions (12, 50). However, limited 
research around usability of HIVST kits has been conducted in SSA, and therefore factors 
that can contribute to an “ideal HIV self-testing kit” need to be evaluated. Educational 
campaigns focused on usage of HIVST kits may be required for target populations not 
exposed to testing through HIVST (12). As literacy and education levels may vary greatly 
for individuals in resource limited settings, delivery method of educational campaigns 
promoting use of HIVST as well as innovative approaches to the packaging of HIVST kits 
will be required.
Costs of test kits for HIVST
Varied responses relating to cost of HIVST kits were noted in literature within SSA (39, 40, 
48). Some participants felt that the government should provide HIVST kits free of charge, 
whilst others were willing to pay for HIVST kits if made available at distribution points that 
would ensure privacy and confidentiality such as pharmacies (38, 48). According to Brown 
et al. (40), accessibility of HIVST kits through pharmacies may increase access to HIVST 
kits, however affordability may be a concern for those individuals who are geographically 
and socioeconomically disadvantaged. Kurth et al. (12) reported that affordability of HIVST 
was a main theme in their behavioural survey data collected. A consensus on cost and 
distribution point of HIVST kit could not be determined as researchers across studies 
reviewed during the scoping review indicated that the cost and distribution point would be 
determined by the target population (38–40, 45, 48). Whilst limited research evidence 
around appropriate cost and distribution points of HIVST kits is available, future research 
should be directed toward identification of the most cost effective HIVST kit and suitable 
distribution points for HIVST kits stratified by target populations.
Informing the scale-up of HIVST
Four of the eleven studies reported on policy and regulations related to HIVST (6, 40, 48, 
49). Some countries within SSA have reportedly integrated HIVST into their existing HIV 
testing policies, but do not have adequate policy and regulatory infrastructure to support 
scale-up of HIVST (6, 48). Qualitative evidence from key stakeholder’s, policy makers and 
healthcare professionals within communities in South Africa, Kenya and Malawi agreed that 
a policy and regulatory framework was essential for HIVST scale-up (38, 48). Van Rooyen 
et al. (48), Choko et al. (49) and Maheswaran et al. (42) reported that mechanisms to 
regulate cost, quality and reliability of HIV ST kits is required for scale-up of HIVST in line 
with WHO guidelines. Limited evidence around implementation of HIVST for scale-up 
exists in SSA. Therefore, policy makers are unable to make informed decisions around 
scale-up of HIVST. Thus, future research that provides evidence around mechanisms to 
regulate cost, quality, reliability, distribution of HIVST kits and linkage to care is required to 
aid policy makers in developing a regulatory framework in line with WHO, UNAIDS and 
local country guidelines for scale-up of HIVST (39, 48, 49).
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DISCUSSION
The results of this scoping review revealed wide-ranging HIVST acceptability levels 
between 22% and 95% in SSA, consistent with findings from other regions of the world. 
However, a more unique pattern of gender disparities in HIVST acceptability rates was 
observed in studies within SSA, with acceptability rates of HIVST being much higher for 
men compared to women. Given men’s natural aversion of healthcare facilities in SSA, the 
review suggest that men may prefer HIVST as it does not require for them to present at 
medical facilities for testing, often associated with loss of income due to absence from work 
(41). Higher acceptability rates amongst men are consistent with studies conducted in 
developed countries among MSM populations (10, 11, 13–15, 17–19). On the contrary, 
routine HIV testing through VCT is presumably higher with women compared to men, as 
women access healthcare facilities through family planning, management of sexually 
transmitted infections and antenatal care during pregnancy (38). Women’s inclination 
towards VCT may render HIVST generally less acceptable to them compared to men, 
although certain sub-groups of women may actually benefit from HIVST. Therefore, further 
understanding of these gender disparities in preferential models for HIV testing is needed to 
inform policy and interventions to optimise HIV testing, including research on the potential 
role and impact of using HIVST to increase uptake of HIV testing and status knowledge 
among male populations, often considered hard-to-reach in SSA. Research is lacking in SSA 
on the use of HIVST among MSM, FSWs and transgender key populations. On the contrary, 
the bulk of the research on HIVST come from regions of the world outside of SSA, 
predominantly developed countries, where the majority of studies were conducted among 
key populations such as MSM and FSWs (27).
Ultimately, adoption and scale-up of HIVST in SSA will depend on the balance between 
potential benefits and related risks. On the one hand, potential benefits of HIVST include 
testing of self in a confidential setting of personal choice (48), testing opportunities for hard-
to-reach populations (38, 51), autonomy in HIV testing (45) and reduction of stigma and 
discrimination impacts associated with testing at HIV testing facilities (52). However, more 
robust studies are needed to demonstrate these benefits, and their impact on HIV testing 
uptake or knowledge of HIV status in clearly-defined target populations. Whilst the potential 
benefit of home-based self-testing on the individuals and their households necessitate further 
research, the presumed reduction of burden on human resources within the health system 
also calls for relevant research. Since most countries in SSA are resource-poor, cost-
effectiveness studies and other resource-related benefits of HIVST will be paramount. On 
the other hand, risks associated with HIVST include potential for coercive testing already 
identified at a small scale in this review, as well as concerns regarding potential self and 
social harms related to lack of counselling, and possible poor linkage to care following a 
positive test result. Careful monitoring and measurement of coercive testing, partner 
violence and suicide will be necessary in suitably-designed studies, as well as the best 
approaches likely to mitigate these potential risks. Such data is needed to inform country-
specific regulatory and policy frameworks for HIVST, as well as responsible scale-up, which 
remain as important gaps globally (3, 13). In SSA, formative research studies around 
costing, access points, user-friendly test kits packaging, monitoring and evaluation systems, 
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quality assurance measures and appropriate HIV counselling approaches are still required 
for the development of regulatory support systems and policy guidelines for implementation 
of HIVST (3, 23, 41).
Policy guidance will also need to inform adoption of suitable HIVST test kits, taking into 
account diversity in target populations, options and reliability of testing methods, 
components of test kits adopted, clarity of user instructions appropriate to varying literacy 
levels, disposal of the test kit, counselling approaches and linkage to care options. Several 
studies have reported that evidence on the usability of HIVST kits remains limited globally, 
including major gaps in SSA (14, 23, 24, 50). Global evidence on counselling approaches 
for HIVST is mixed, also observed in this review. According to a study in Hong Kong, 16% 
of MSM preferred HIVST due to absence of face-to-face counselling (53). However, a study 
in Peru reported 87% of participants required face-to-face counselling by trained counsellors 
(26). International policy no longer advocates for face-to-face HIV counselling, and suggests 
use of toll-free numbers for counselling (48), which highlights the need for further research 
to explore suitable counselling and training approaches for users of HIVST, with clear 
linkages to care (54). Whilst linkage to care may be hindered by travel costs to health 
facilities, a known barrier to access, the cost and accessibility of HIVST test kits may 
constitute the first barrier likely to prevent awareness of HIV status. Participants in middle to 
high-income countries are more willing to pay for test kits, when compared to participants 
from low-income countries (53). In SSA, cost to purchase HIVST kits will likely compete 
with daily necessities such as food and housing due to high levels of poverty to the exclusion 
of relatively wealthier individuals. Also, the cost of the test kit will likely influence location 
of distribution points (13). These may include, but are not limited to local clinics, 
supermarkets, bars or restaurants and condom distribution points (19). Therefore, an 
affordable or a government-subsidised HIVST kit may be required for successful scale-up of 
HIVST to accommodate geographically hard-to-reach and poverty-stricken populations. 
Cost of HIVST kits has not been extensively evaluated globally, thus requiring additional 
research to reduce the economic burden on an individual as well as limit cost implications 
for governments and other health providers.
CONCLUSIONS
Overall, this scoping review highlighted a broad range of acceptability rates for HIVST in 
SSA, very similar global rates, although men seem to benefit more from HIVST than 
women. However, the body of research on HIVST is still in its infancy stage relative to the 
global literature, except for research on policy guidance and frameworks on HIVST, which 
seems to lag behind across many countries of the world. Additional priorities for research on 
HIVST in SSA should be targeted at the information needed to inform scale-up and wider 
adoptions in the context of very diverse populations in education, wealth, geographical 
access and most likely socio-cultural values. These research priorities should include types 
of target populations, location of HIVST, packaging of test kits, appropriate counselling 
services, social protection from harm, conducive policy frameworks, and demonstrable 
impact on the uptake of HIV testing and levels of HIV status awareness. Whilst HIVST has 
the potential to complement current HIV testing models which could lead to increased 
uptake of HIV testing, HIV status awareness and earlier initiation of ART, much 
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implementation research work is still needed in SSA to contribute towards evidence base for 
the responsible scale-up of HIVST.
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Figure 1. 
Flow chart depicting process of article selection for scoping study
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